A 58-year-old man with end-stage renal disease presents to the emergency department with progressive weakness and palpitations. He missed his last dialysis session. On examination, he appears anxious and diaphoretic. Pulse is 52/min and irregular. An ECG shows new T wave changes. Laboratory studies reveal serum potassium of 7.2 mEq/L. Which of the following is the most appropriate immediate next step in management? (PGMI Recall)
- AIV regular insulin with dextrose
- BNebulised salbutamol
- CEmergency haemodialysis
- DCalcium gluconate intravenously
- EOral sodium polystyrene sulfonate
Show the answer and explanation
Answer: D — Calcium gluconate intravenously
This is severe hyperkalaemia (7.2 mEq/L) with ECG changes, and the point tested is the order of treatment. Once the ECG is affected the immediate danger is a fatal arrhythmia, so the first drug must protect the myocardium rather than lower potassium; the slow irregular pulse adds urgency. Intravenous calcium gluconate, 30 mL of 10% over 10 minutes with cardiac monitoring (or 10 mL of 10% calcium chloride), stabilises the cardiac membrane within minutes; it does not lower potassium and its effect lasts only 30 to 60 minutes, so it is repeated if the ECG does not improve. Insulin with glucose is the most effective potassium-shifting treatment and follows immediately, but takes 15 to 30 minutes to work. Nebulised salbutamol is an additional shifting agent with a similar delay. Emergency haemodialysis is the definitive treatment in this patient but cannot be started within minutes. Sodium polystyrene sulfonate acts over hours and has no role in the emergency.